100mg Taxonab Paclitaxel - Protein Bound Particles Injection

Name: 100mg Taxonab Paclitaxel - Protein Bound Particles Injection
Brand: Amari Trade Alliance LLP
Price: 2515 INR
Availability: InStock

Price 2515 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

100mg Taxonab Paclitaxel - Protein Bound Particles Injection Specification

Pacakaging (Quantity Per Box)
1 vial/box

Dosage Form
Injection

Life Span
24-36 months

Origin of Medicine
India

Packaging Type
Vial

Brand Name
Taxonab

Salt Composition
Paclitaxel - Protein Bound Particles

Indication
Metastatic breast cancer, NSCLC, pancreatic cancer

Drug Type
Antineoplastic

Ingredients
Paclitaxel, Human Albumin

Physical Form
Lyophilized powder

Function
Cancer treatment, cytotoxic

Recommended For
Chemotherapy, Cancer treatment

Dosage
100 mg

Dosage Guidelines
As directed by oncologist

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C, protect from light

Appearance
White powder

Protein Free Solvent
No

Dilution
Required before infusion

Latex Free
Yes

Reconstitution
Required before use

Cytotoxic Handling
Yes

Route
Intravenous

Prescription
Required

100mg Taxonab Paclitaxel - Protein Bound Particles Injection Trade Information

Minimum Order Quantity
10 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About 100mg Taxonab Paclitaxel - Protein Bound Particles Injection

Experience the elite benefits of 100mg Taxonab Paclitaxel - Protein Bound Particles Injection, an exclusive and cost-effective solution for formidable cancer treatment. This unparalleled, limited-time offer features a lyophilized white powder that requires reconstitution and dilution before infusion via intravenous route. Packaged in a latex-free, protein-free solvent vial, Taxonab is recommended for chemotherapy in adults with metastatic breast, non-small cell lung, or pancreatic cancers. Adhering to stringent cytotoxic handling guidelines, Taxonab stands as a reliable choice for oncologists seeking advanced, prescription-only antineoplastic therapy from India.

Specific Usage and Versatile Applications

100mg Taxonab Paclitaxel injection is specifically indicated for the treatment of metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer in adults. It excels as a formidable cytotoxic agent in chemotherapy protocols. Reconstitution is required prior to use, following strict direction by an oncologist. While Taxonab is mainly for oncology, its unmatched efficacy extends to various advanced cancer regimens as approved by specialists. Always adhere to prescribed dosages and dilution instructions for optimal therapeutic outcomes.

Delivery Time, Supply Capacity, and Market Reach

We charge standard rates to supply 100mg Taxonab injections promptly across India's main domestic market, with formidable supply ability ensuring timely delivery and constant availability. Upon confirmed exchange, products are shipped securely, typically within a few business days. Our elite distribution network enables reliable access, meeting the needs of exporters, suppliers, and traders nationwide. For those requiring continuous, cost-effective oncology treatments, Taxonab is consistently stocked and delivered under optimal storage guidelines.

FAQ's of 100mg Taxonab Paclitaxel - Protein Bound Particles Injection:

Q: How should 100mg Taxonab Paclitaxel - Protein Bound Particles Injection be administered?

A: The injection must be reconstituted and diluted before use, then administered intravenously by a qualified healthcare professional as per your oncologist's directions.

Q: What are the main indications for using Taxonab Paclitaxel injection?

A: Taxonab is primarily indicated for metastatic breast cancer, non-small cell lung cancer (NSCLC), and pancreatic cancer in adults undergoing chemotherapy.

Q: When is reconstitution of the product necessary?

A: Reconstitution of Taxonab is required immediately before administration, ensuring proper preparation just prior to the intravenous infusion.

Q: Where should Taxonab be stored before use?

A: Store the injection vial below 25C and protect it from light, as per the manufacturer's recommended storage instructions.

Q: What is the process for safe cytotoxic handling of Taxonab?

A: Handling should be performed by trained personnel using appropriate personal protective equipment and following cytotoxic drug handling protocols to ensure safety.

Q: What benefit does protein-bound particle formulation provide in Taxonab Paclitaxel?

A: The protein-bound formulation enhances drug delivery to tumor sites, potentially increasing efficacy while reducing some adverse reactions associated with traditional solvents.

Tell us about your requirement